Literature DB >> 25053617

The chemokine CXC4 and CC2 receptors form homo- and heterooligomers that can engage their signaling G-protein effectors and βarrestin.

Sylvain Armando1, Julie Quoyer2, Viktorya Lukashova2, Arhamatoulaye Maiga2, Yann Percherancier2, Nikolaus Heveker3, Jean-Philippe Pin4, Laurent Prézeau4, Michel Bouvier5.   

Abstract

G-protein-coupled receptors have been shown to assemble at least as dimers early in the biosynthetic path, but some evidence suggests that they can also form larger oligomeric complexes. Using the human chemokine receptors CXCR4 and CCR2 as models, we directly probed the existence of higher order homo- and heterooligomers in human embryonic kidney cells. Combining bimolecular fluorescence and luminescence complementation (BiFC, BiLC) with bioluminescence resonance energy transfer (BRET) assays, we show that CXCR4 and CCR2 can assemble as homo- and heterooligomers, forming at least tetramers. Selective activation of CCR2 with the human monocyte chemotactic protein 1 (MCP-1) resulted in trans-conformational rearrangement of the CXCR4 dimer with an EC50 of 19.9 nM, compatible with a CCR2 action. Moreover, MCP-1 promoted the engagement of Gαi1, Gα13, Gαz, and βarrestin2 to the heterooligomer, resulting in calcium signaling that was synergistically potentiated on coactivation of CCR2 and CXCR4, demonstrating that complexes larger than dimers reach the cell surface as functional units. A mutation of CXCR4 (N119K), which prevents Gi activation, also affects the CCR2-promoted engagement of Gαi1 and βarrestin2 by the heterooligomer, supporting the occurrence of transprotomer regulation. Together, the results demonstrate that homo- and heteromultimeric CXCR4 and CCR2 can form functional signaling complexes that have unique properties. © FASEB.

Entities:  

Keywords:  GPCR; allosteric regulation; complex formation; protein complementation assays; resonance energy transfer; transactivation

Mesh:

Substances:

Year:  2014        PMID: 25053617     DOI: 10.1096/fj.13-242446

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  12 in total

Review 1.  G Protein-Coupled Receptor Heteromers.

Authors:  Ivone Gomes; Mohammed Akli Ayoub; Wakako Fujita; Werner C Jaeger; Kevin D G Pfleger; Lakshmi A Devi
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-22       Impact factor: 13.820

2.  Monitoring ligand-dependent assembly of receptor ternary complexes in live cells by BRETFect.

Authors:  David Cotnoir-White; Mohamed El Ezzy; Pierre-Luc Boulay; Marieke Rozendaal; Michel Bouvier; Etienne Gagnon; Sylvie Mader
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-27       Impact factor: 11.205

3.  Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRs.

Authors:  Charlotte Avet; Arturo Mancini; Billy Breton; Christian Le Gouill; Alexander S Hauser; Claire Normand; Hiroyuki Kobayashi; Florence Gross; Mireille Hogue; Viktoriya Lukasheva; Stéphane St-Onge; Marilyn Carrier; Madeleine Héroux; Sandra Morissette; Eric B Fauman; Jean-Philippe Fortin; Stephan Schann; Xavier Leroy; David E Gloriam; Michel Bouvier
Journal:  Elife       Date:  2022-03-18       Impact factor: 8.713

4.  Functional interaction between angiotensin II receptor type 1 and chemokine (C-C motif) receptor 2 with implications for chronic kidney disease.

Authors:  Mohammed Akli Ayoub; Yuan Zhang; Robyn S Kelly; Heng B See; Elizabeth K M Johnstone; Elizabeth A McCall; James H Williams; Darren J Kelly; Kevin D G Pfleger
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

5.  Closely related, yet unique: Distinct homo- and heterodimerization patterns of G protein coupled chemokine receptors and their fine-tuning by cholesterol.

Authors:  Stefan Gahbauer; Kristyna Pluhackova; Rainer A Böckmann
Journal:  PLoS Comput Biol       Date:  2018-03-12       Impact factor: 4.475

6.  Signal profiling of the β1AR reveals coupling to novel signalling pathways and distinct phenotypic responses mediated by β1AR and β2AR.

Authors:  Viktoriya Lukasheva; Dominic Devost; Christian Le Gouill; Yoon Namkung; Ryan D Martin; Jean-Michel Longpré; Mohammad Amraei; Yuji Shinjo; Mireille Hogue; Monique Lagacé; Billy Breton; Junken Aoki; Jason C Tanny; Stéphane A Laporte; Graciela Pineyro; Asuka Inoue; Michel Bouvier; Terence E Hébert
Journal:  Sci Rep       Date:  2020-05-29       Impact factor: 4.379

7.  Coexpression of CCR7 and CXCR4 During B Cell Development Controls CXCR4 Responsiveness and Bone Marrow Homing.

Authors:  Saria Mcheik; Nils Van Eeckhout; Cédric De Poorter; Céline Galés; Marc Parmentier; Jean-Yves Springael
Journal:  Front Immunol       Date:  2019-12-18       Impact factor: 7.561

8.  New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth Muscle.

Authors:  Ann E Evans; Abhishek Tripathi; Heather M LaPorte; Lioubov I Brueggemann; Abhay Kumar Singh; Lauren J Albee; Kenneth L Byron; Nadya I Tarasova; Brian F Volkman; Thomas Yoonsang Cho; Vadim Gaponenko; Matthias Majetschak
Journal:  Int J Mol Sci       Date:  2016-06-20       Impact factor: 5.923

9.  FFAR2-FFAR3 receptor heteromerization modulates short-chain fatty acid sensing.

Authors:  Zhiwei Ang; Ding Xiong; Min Wu; Jeak Ling Ding
Journal:  FASEB J       Date:  2017-09-07       Impact factor: 5.191

10.  Advanced fluorescence microscopy reveals disruption of dynamic CXCR4 dimerization by subpocket-specific inverse agonists.

Authors:  Ali Işbilir; Jan Möller; Marta Arimont; Vladimir Bobkov; Cristina Perpiñá-Viciano; Carsten Hoffmann; Asuka Inoue; Raimond Heukers; Chris de Graaf; Martine J Smit; Paolo Annibale; Martin J Lohse
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.